Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Forward Pharma Operations ApS
APS
In liquidation
Advertising protection
CVR 38757504
Strandvejen 125, 2900
Hellerup
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2017 · 8 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Forward Pharma Operations ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2020
1M
2021
1M
2022
1M
2023
0M
2024
EBITDA
DKK millions
0M
-3M
-6M
-8M
-11M
-8M
2020
-9M
-12%
2021
-8M
+11%
2022
-2M
+75%
2023
-2M
0%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Revenue
351
622
724
547
99
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-8.158
-9.004
-7.895
-2.342
-2.254
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-8.158
-9.004
-7.895
-2.342
-2.254
Net financials
-1.951
-483
-19.127
3.385
-66.067
Profit before tax
-10.109
-9.487
-27.022
1.043
-68.320
Tax
-0
-0
-0
-0
23
Net profit
-10.109
-9.487
-27.022
1.043
-68.344
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
337.159
327.107
305.109
302.114
349.447
Equity
314.592
305.105
278.083
279.126
280.041
Long-term debt
0
0
0
0
0
Short-term debt
22.567
22.001
27.026
22.988
69.406
Total debt
22.567
22.001
27.026
22.988
69.406
Financial ratios
5-year trend
EBITDA margin
-2273.4%
This company
15.8%
Market median
-14489% vs market
2020
2024
Equity ratio
80.1%
This company
38.2%
Market median
+110% vs market
2020
2024
Return on equity
-24.4%
This company
18.4%
Market median
-233% vs market
2020
2024
Net profit margin
-68945.7%
This company
8.1%
Market median
-851281% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on Forward Pharma Operations ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
